WHO suspends hydroxychloroquine trials

Published



The World Health Organization is temporarily suspending the use of hydroxychloroquine from its global study into experimental treatments for the coronavirus.

WHO Director-General Tedros Adhanom Ghebreyesus said in a news briefing Monday that a study published last week showed those taking hydroxychloroquine had a greater risk of heart problems and death.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.